Skip to main content

FDA Concerns re DHASCO®/ARASCO® Infant Formula Additives

In 2001 Martek Biosciences, Inc. petitioned the FDA to recognize the company's self-certified Generally Recognized as Safe (GRAS) status for its ARA fungal oil (ARASCO®) and DHA algal oil (DHASCO®) infant formula ingredients.

The Generally Recognized as Safe designation is a U.S. industry devised mechanism to avoid due diligence.  Additives, classified generally recognized as safe, enter consumer products without premarket approval and independent testing.

Some researchers are of the opinion that the ARASCO®/DHASCO® products, which contain long-chain polyunsaturated fatty acids (LCPUFAs), are infant health risks.

The FDA agreed to accept the Martek Biosciences, generally recognized as safe, claims but countered that further DHASCO®/ARASCO®, testing was warranted because:

... some studies have reported unexpected deaths among infants who consumed formula supplemented with LCPUFAs. These unexpected deaths were attributed to Sudden Infant Death Syndrome (SIDS), sepsis or necrotizing  enterocolitis. Also, some studies have reported adverse events and other morbidities including diarrhea, flatulence, jaundice, and apnea in infants fed LCPUFAs.
Diethylene Glycol Deaths Prompt Regulatory Action

In September 1937 the S. E. Massengill Company began marketing an antibiotic product called elixir sulfanilamide. The medication contained the dissolving agent Diethylene glycol, a known toxic substance.

Elixir Sulfanilamide was responsible for 100 deaths, many of them children.  Dr. Samuel E. Massengill pleaded guilty to the federal charges of adulteration/misbranding of the company's product and paid fines.

Following the "Taste of Raspberries, Taste of Death" poisoning Congress expediently passed the 1938 Food, Drug, and Cosmetic Act

Congressional actions twenty years later compromised the intent of the 1938 legislation and the ability of the Federal Drug Administration to protect consumers from injurious products.

The 1958 pro-industry Food Additives Amendment, aka "The GRAS Law"  permits
financially-positioned entities to establish the safety and suitability of their products by way of industry-sponsored trials and selected approval panels.

Martek Biosciences Response to FDA: Supplemental DHASCO®/ARASCO® Safety Studies "Would not be Productive"

Martek Biosciences   informed the FDA that further, DHASCO®/ARASCO®, safety studies "would not be productive":

As such it is doubtful that convening a group of experts to answer purely hypothetical concerns would be scientifically productive, but such a step would certainly and unnecessarily further delay the availability of the proven clinical benefits of Arasco/Dhasco-supplementation to preterm and term infants of American families.
The Agency and the courts have long held that GRAS determination requires neither unanimity nor the absence of a conflict in the scientific community.
ARASCO and DHASCO pose unique testing problems because it can be difficult to distinguish whether an observed effect related to the test material is a normal physiological response to the high dietary load of that particular macronutrient, a dietary deficiency that is related to presence of a large amount of the test material in the diet, or a toxicological effect.
...studies conducted in term and preterm infants with balanced addition of ARASCO and DHASCO as sources of both bioactive fatty acids showed no difference in deaths between treatment and control groups.
...some studies have reported changes attributed to possible effects on the kidney. Martek presents an analysis of these studies and concludes that there are no consistent treatment related effects of DHASCO and ARASCO, either alone or in combination, with respect to kidney weight, kidney function or kidney histopathology.
The question of whether the DHASCO® and ARASCO® oils are benign/beneficial infant formula additives remains unknown because Martek Biosciences would not support the FDA's position that:
any evaluation that a use of a food ingredient is safe is a time-dependent judgment that is based on general scientific knowledge as well as specific data and information about the ingredient.
Wyeth-Ayerst 1998 Notice of Claim to the FDA for ARASCO/DHASCO Oils' Exemption from Premarket Approval

In its FDA waiver request letter, Wyeth-Ayerst affirmed that the products:

...conditions of use are such that ARASCO and DHASCO will comprise less than 3.5% of an infant formula fat blend, their use does not meaningfully affect the overall content of heavy metals, pesticides, trans fatty acids, residual extraction solvent, or non-saponifiables in the infant formulas in which they are used.
Wythe-Ayerst initiated research trials found that (US/Canada) infant study groups supplied with ARASCO/DHASCO enhanced formula "grew significantly better than the human milk fed group." The Wythe-Ayerst claim is not supportable.

As a result of its and other industry-funded animal/infant research projects, Wythe concludes that "the safety and tolerance of the of the Arasco and Dhasco-supplemented formula" is well documented and needs no further inquiry.

Martek Biosciences DHASCO® ARASCO® Business Matters

Bloomberg Businessweek advised interested parties— "A Growing Boost for Baby Formula"—that Martek's first-mover  DHASCO/ARASCO status and the company's 15-24 year contracted partnerships with 14 infant formula producers were favorable investment factors.

A federal anti-trust lawsuit was filed against Martek Biosciences, Inc. in 2011. The plaintiff, BNLfoods, claimed that Martek Biosciences had achieved a U.S. infant formula ARA fungal oil/DHA algal oil additives monopoly.

DHASCO®/ARASCO® Oils Classified Organic

It is instructive to consider the Martek Biosciences organic certification revenue strategy:

If our oils are unable to be used in organic food and beverage products, the opportunity for sales of our oils into the food and beverage market will be limited to non-organic products.
The fifteen member National Organic Standards Board determined during their fall 2011 Savannah meeting that Martek Biosciences DHA algal and ARA fungal oils should be included on the National List as organic substances. This recommendation was made in spite of the fact the ARASCO® and DHASCO® additives (Formulaid®) are:
derived from genetically mutated algae and soil fungus, are processed with petrochemical solvents, grown in genetically engineered corn, and formulated for use in infant formula, dairy and other products with a myriad of other unreviewed synthetic ingredients.
Reference: The Organic WatergateCornucopia Institute

Martek Biosciences 2010 Petition to the National Organic Standards Board for Organic Certification

Martek Bioscience, Inc. notified the National Organic Standards Board in its 2010 request that the inclusion of negative DHA algal/ANA fungal oil information was unjustified:

Martek also is concerned that by quoting the Cornucopia report, the TAP (Technical Advisory Panel) could be creating the unintentional impression that it has reviewed the underlying data and believes that there is some legitimacy to the positions advanced by Cornucopia.
International Formula Council Complaints

The May 2012 International Formula Council's letter to the National Organic Standards Board warned that unfavorable findings on the part of the Board re infant formula product substances such as choline, inositol, carrageenan, and arachididontic acid might result in market disruption and force manufacturers to reconsider whether to continue in the organic baby formula business.

International Formula Council members: Abbott Nutrition, Mead Johnson Nutrition, Nestlé Infant Nutrition, PBM Products, LLC, A Perrigo Company, and Pfizer Nutrition are of the opinion that hexane-extracted ingredients are suitable for inclusion on the National Organic List.

For a historic perspective on harmful industry marketing concepts please read the 1981 NYT report: "The Controversy Over Infant Formula."  In summary: The World Health Organization agreed by a vote of 118 to l that infant-formula advertising should be restricted. The U.S. was the lone opponent.

Is the U.S.D.A. certified-organic label meaningless?  Evidence supplied by The New York Times and others indicate that the National Organic Standards Board is and has been unduly influenced by financial interests.

National Organic Standards Board May 25, 2012 recommendations: add synthetic ingredients, choline and inositol to the National Organic List. Carrageenan, another synthetic product, was allowed to remain on the National Organic List but is considered unsuitable for use in infant, under six months, formula. The World Health Organization advises that carrageenan should not be added to infant formulas. Some studies referenced by WHO suggest that degraded carrageenan may be a "possible human carcinogen."  Carrageenan is present in food products, pet food and pharmaceuticals. Carrageenan's primary production site is the Philippines.

Your Email has been sent.
You must add at least one tag to this diary before publishing it.

Add keywords that describe this diary. Separate multiple keywords with commas.
Tagging tips - Search For Tags - Browse For Tags


More Tagging tips:

A tag is a way to search for this diary. If someone is searching for "Barack Obama," is this a diary they'd be trying to find?

Use a person's full name, without any title. Senator Obama may become President Obama, and Michelle Obama might run for office.

If your diary covers an election or elected official, use election tags, which are generally the state abbreviation followed by the office. CA-01 is the first district House seat. CA-Sen covers both senate races. NY-GOV covers the New York governor's race.

Tags do not compound: that is, "education reform" is a completely different tag from "education". A tag like "reform" alone is probably not meaningful.

Consider if one or more of these tags fits your diary: Civil Rights, Community, Congress, Culture, Economy, Education, Elections, Energy, Environment, Health Care, International, Labor, Law, Media, Meta, National Security, Science, Transportation, or White House. If your diary is specific to a state, consider adding the state (California, Texas, etc). Keep in mind, though, that there are many wonderful and important diaries that don't fit in any of these tags. Don't worry if yours doesn't.

You can add a private note to this diary when hotlisting it:
Are you sure you want to remove this diary from your hotlist?
Are you sure you want to remove your recommendation? You can only recommend a diary once, so you will not be able to re-recommend it afterwards.
Rescue this diary, and add a note:
Are you sure you want to remove this diary from Rescue?
Choose where to republish this diary. The diary will be added to the queue for that group. Publish it from the queue to make it appear.

You must be a member of a group to use this feature.

Add a quick update to your diary without changing the diary itself:
Are you sure you want to remove this diary?
(The diary will be removed from the site and returned to your drafts for further editing.)
(The diary will be removed.)
Are you sure you want to save these changes to the published diary?

Comment Preferences

  •  Eicosopentenoic acid is synthesized by one and... (5+ / 0-)

    only one species of mammal, the human being, and only one of humanity's two sexes, the female, and only at one point in her life, when she's lactating.

    It is generally believed that human females evolved this ability to biosynthesize an important PUFA in connection with the rise of the human brain.   The neurological benefits of this compound are pretty well known.   One of the important reasons to breastfeed is thought to involve PUFA's, specifically EPA.

    In fact, all of the other PUFAs synthesized on earth, including fish oil, are biosynthesized in algae.    Fish contain these nearly essential oils by being high up on the food chain in species where the primary energy source is, um, algae.

    (Some terrestrial plants also produce PUFA's with their well known benefits:   Black walnuts are one excellent example of such a plant.)

    One now generally expects fear, ignorance and superstition to be widely espoused in the name of being "organic" where the term organic has been removed from its scientific meaning by people who generally hate science.

    One of the disappointing things that I learned while blogging on the left, despite having long identified as a leftist, is that fear and ignorance are as widely distributed on the far left as on the far right.

    Have a nice evening.

  •  Actually, (1+ / 0-)
    Recommended by:
    Urban Owl

    carrageenan is a natural product of seaweed, which may or may not be refined or further processed for use as a gelatin/thickener in food items. FAO/WHO dis-recommend its use in infant formulas because it's a high molecular weight polysaccharide. High molecular weight polysaccharides (and proteins, and other molecular classes) can trigger allergies/sensitivities. Degraded carrageenan (aka poligeenan) is suspected from rat, guinea pig and monkey studies to cause gastro-intestinal ulcers and/or gastro-intestinal cancers. Degradation to smaller molecules of poligeenan is caused by high processing temperatures and acidic conditions.

    So while often refined and/or processed, carrageenan is not a "synthetic" food additive.

  •  The assertion that self-certified GRAS is an (3+ / 0-)
    Recommended by:
    kyril, alain2112, eyesoars

    industry scam is unwarrented and false. In fact it is a marker on the way to obtaining FDA GRAS (generally regarded as safe). Research has to be vetted by an independent scientific panel. An example of the kind of research done is this
    project on these supplements by an Australian government project. The summary was

    "A large number of clinical studies with pre-term and term infants have been undertaken with
    infant formula supplemented with DHASCO and ARASCO at levels producing ARA and DHA concentrations approximating those found in human milk.  These were primarily undertaken for the purposes of establishing efficacy, however a number also examined how
    well the supplemented formulae were tolerated and whether its use was correlated with any adverse effects (e.g., reduced growth, changes in serological markers of spleen and liver function).  These studies all indicate that formula supplemented with DHASCO and ARASCO is well tolerated by human infants and is not associated with any apparent adverse effects. "
      Science one (won); diary zero.

    I'd tip you but they cut off my tip box. The TSA would put Moses, Jesus, and Muhammad on the no-fly list.

    by OHdog on Tue Feb 05, 2013 at 06:34:20 PM PST

Subscribe or Donate to support Daily Kos.

Click here for the mobile view of the site